Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)
- 27 October 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 68 (4), 844-852
- https://doi.org/10.1016/j.mehy.2006.08.041
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pathological gambling is linked to reduced activation of the mesolimbic reward systemNature Neuroscience, 2005
- Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndromeAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
- Overexpression of dopamine D2 receptors reduces alcohol self‐administrationJournal of Neurochemistry, 2001
- Brain dopamine and obesityThe Lancet, 2001
- The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive BehaviorsJournal of Psychoactive Drugs, 2000
- Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of ObesityPublished by American Medical Association (AMA) ,1996
- Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replicationBiological Psychiatry, 1996
- Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependencePsychopharmacology, 1994
- Allelic Association of the D2 Dopamine Receptor Gene With Receptor-Binding Characteristics in Alcoholism or Gene ismArchives of General Psychiatry, 1991
- Allelic Association of Human Dopamine D2 Receptor Gene in AlcoholismJAMA, 1990